Patricia Drake
Corporate Officer/Principal bij TREVENA, INC.
Vermogen: 41 760 $ op 31-05-2024
Profiel
Patricia Drake is currently the Chief Commercial Officer & Senior Vice President at Trevena, Inc. Prior to this, she was the Chief Executive Officer & Managing Director at MSD Finland Oy from 2019 to 2021, and the Chief Commercial Officer at Sesen Bio, Inc. in 2021.
She completed her undergraduate degree at Wichita State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
TREVENA, INC.
0.58% | 14-12-2023 | 107 078 ( 0.58% ) | 41 760 $ | 31-05-2024 |
Actieve functies van Patricia Drake
| Bedrijven | Functie | Begin |
|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 11-11-2021 |
Eerdere bekende functies van Patricia Drake
| Bedrijven | Functie | Einde |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-09-2021 |
| MSD Finland Oy | Algemeen Directeur | 01-05-2021 |
Opleiding van Patricia Drake
| Wichita State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| MSD Finland Oy |
